BRIACELL THERAPEUTICS CORP. Shares Issued
BRIACELL THERAPEUTICS CORP. (BCTX) had Shares Issued of 7.25 million shares as of 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-06-09
- 2026-04-30: Common Stock, Shares, Issued 7.25M shares.
- 2026-01-31: Common Stock, Shares, Issued 7.25M shares.
- 2025-07-31: Common Stock, Shares, Issued 1.88M shares.
- 2025-04-30: Common Stock, Shares, Issued 6.56M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-04-30 | 7.25M shares 10-Q · filed 2026-06-09 | |
| 2026-01-31 | 7.25M shares 10-Q · filed 2026-03-10 | |
| 2025-07-31 | 1.88M shares 10-Q · filed 2026-06-09 | |
| 2025-04-30 | 6.56M shares 10-Q · filed 2025-06-16 | |
| 2024-10-31 | 36.18M shares 10-Q · filed 2024-12-16 | |
| 2024-07-31 | 121.91K shares 10-K · filed 2025-10-16 | 18.28M shares 10-K · filed 2024-10-29 |
| 2024-04-30 | 15.98M shares 10-Q · filed 2024-06-14 | |
| 2024-01-31 | 15.98M shares 10-Q · filed 2024-03-18 | |
| 2023-10-31 | 15.98M shares 10-Q · filed 2023-12-14 | |
| 2023-07-31 | 15.98M shares 10-K · filed 2024-10-29 | |
| 2023-04-30 | 15.52M shares 10-Q · filed 2023-06-14 | |
| 2023-01-31 | 15.52M shares 10-Q · filed 2023-03-16 | |
| 2022-10-31 | 15.52M shares 10-Q · filed 2022-12-14 | |
| 2022-07-31 | 15.52M shares 10-K · filed 2023-10-25 | |
| 2021-07-31 | 15.27M shares 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |